These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 25906447)
1. Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma. Kawabata Y; Nishi T; Kidani A; Tajima Y Pancreas; 2015 Aug; 44(6):937-44. PubMed ID: 25906447 [TBL] [Abstract][Full Text] [Related]
2. Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection. Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sueda T Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S646-55. PubMed ID: 22086444 [TBL] [Abstract][Full Text] [Related]
3. Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. Koopman M; Venderbosch S; van Tinteren H; Ligtenberg MJ; Nagtegaal I; Van Krieken JH; Punt CJ Eur J Cancer; 2009 Jul; 45(11):1999-2006. PubMed ID: 19457654 [TBL] [Abstract][Full Text] [Related]
4. An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatment. Fisher SB; Patel SH; Bagci P; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Maithel SK Cancer; 2013 Jan; 119(2):445-53. PubMed ID: 22569992 [TBL] [Abstract][Full Text] [Related]
5. Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy. Fisher SB; Fisher KE; Patel SH; Lim MG; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Farris AB; Maithel SK Cancer; 2013 Jan; 119(2):454-62. PubMed ID: 22760605 [TBL] [Abstract][Full Text] [Related]
6. Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy. Okamura Y; Yasukawa S; Narimatsu H; Boku N; Fukutomi A; Konishi M; Morinaga S; Toyama H; Kaneoka Y; Shimizu Y; Nakamori S; Sata N; Yamakita K; Takahashi A; Kainuma O; Hishinuma S; Yamaguchi R; Nagino M; Hirano S; Yanagisawa A; Mori K; Uesaka K Cancer Sci; 2020 Feb; 111(2):548-560. PubMed ID: 31778273 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma. Sakabe R; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakashima A; Ohge H; Sueda T; Hiyama E Ann Surg Oncol; 2012 Sep; 19(9):3072-80. PubMed ID: 22322954 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202 [TBL] [Abstract][Full Text] [Related]
9. Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer. Santini D; Perrone G; Vincenzi B; Lai R; Cass C; Alloni R; Rabitti C; Antinori A; Vecchio F; Morini S; Magistrelli P; Coppola R; Mackey JR; Tonini G Ann Oncol; 2008 Apr; 19(4):724-8. PubMed ID: 18187485 [TBL] [Abstract][Full Text] [Related]
10. Impact of intratumoral thymidylate synthase expression on prognosis after surgical resection for ampullary carcinoma. Kato Y; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Hiyama E; Sueda T J Surg Oncol; 2011 Jun; 103(7):663-8. PubMed ID: 21360535 [TBL] [Abstract][Full Text] [Related]
12. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study. Robert PE; Leux C; Ouaissi M; Miguet M; Paye F; Merdrignac A; Delpero JR; Schwarz L; Carrere N; Muscari F; Gayet B; Dussart D; Hamy A; Regenet N Pancreas; 2014 Jul; 43(5):692-7. PubMed ID: 24713843 [TBL] [Abstract][Full Text] [Related]
13. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine. Tokunaga Y; Takahashi K; Saito T Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763 [TBL] [Abstract][Full Text] [Related]
14. The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma. Showalter TN; Zhan T; Anne PR; Chervoneva I; Mitchell EP; Yeo CJ; Rosato EL; Kennedy EP; Berger AC J Gastrointest Surg; 2011 Aug; 15(8):1411-6. PubMed ID: 21523621 [TBL] [Abstract][Full Text] [Related]
15. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study). Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805 [TBL] [Abstract][Full Text] [Related]
16. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
17. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer. Santini D; Vincenzi B; Fratto ME; Perrone G; Lai R; Catalano V; Cass C; Ruffini PA; Spoto C; Muretto P; Rizzo S; Muda AO; Mackey JR; Russo A; Tonini G; Graziano F J Cell Physiol; 2010 May; 223(2):384-8. PubMed ID: 20082300 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China. Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of ERCC1 expression in breast cancer. Gerhard R; Carvalho A; Carneiro V; Bento RS; Uemura G; Gomes M; Albergaria A; Schmitt F Pathol Res Pract; 2013 Jun; 209(6):331-6. PubMed ID: 23702380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]